Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models

Fig. 6

Expansion of antigen-specific T cells in a CMV model system under suppressive conditions. Monocytes and T cells were isolated from peripheral blood mononuclear cells of donors screened for having CMV-specific T cells. Monocytes were differentiated with GM-CSF/IL-4 to immature dendritic cells (DCs). DCs were infected with LOAd(-), LOAd703 or LOAd7032, or stimulated with Poly(I:C)/TNFα (positive control), or left untreated. 24 h later, DCs were pulsed with the CMV peptide pp65 and co-cultured with autologous T cells with and without the addition of TGF-β1 and IL-10. After 11 days of co-culture, cells were harvested and analyzed with flow cytometry. The box plots show the median and quartiles and whiskers display the minimum and maximum (n = 6). The data is displayed as a percentage fold change compared to control conditions. In A, the expanded cell types are shown (CMV-specific T cells (CD3 + CD8 + CMVtet +), natural killer (NK) cells (CD3-CD56 +/ CD16 +) and regulatory T cells (Tregs: CD3 + CD4 + CD25 + CD127low/-)) (A). In B, exhaustion/activation markers on CMV-specific T cells are shown. Note, CD69 expression is analyzed on CD8 + T cells (B). In C, the different phenotypes of CD8 + T cells are displayed (Effector: CD45RA + CCR7-, Naïve: CD45RA + CCR7 + , Central memory (CM): CD45RA-CCR7 + , Effector memory (EM): CD45RA-CCR7-) (C). Statistical differences between LOAd samples and positive control samples were determined with Kruskal–Wallis test followed by Dunn’s multiple comparison test (*p < 0.05, **p < 0.01)

Back to article page